RS
LXRX icon

R Squared’s Lexicon Pharmaceuticals LXRX Stock Holding History

R Squared’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Sell
54,985
-12,541
-19% -$24.4K 0.07% 381
2026
Q1 		$105K Buy
67,526
+20,947
+45% +$30.5K 0.06% 361
2025
Q4 		$53.6K Buy
46,579
+14,530
+45% +$20K 0.03% 453
2025
Q3 		$43.3K Buy
32,049
+2,490
+8% +$2.83K 0.02% 500
2025
Q2 		$28K Buy
+29,559
New +$19.2K 0.02% 428
2025
Q1 		– Sell
-3,040
Closed -$2.25K – 967
2024
Q4 		$2.25K Buy
+3,040
New +$3.66K ﹤0.01% 1449

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

R Squared's LXRX Position: Q2 2026 in Review

R Squared reduced its Lexicon Pharmaceuticals (LXRX) stake by 19% in Q2 2026, selling an estimated $24.4K and leaving 54,985 shares worth $132K. The position accounts for 0.07% of the portfolio, ranked #381.

R Squared first reported a position in LXRX in Q4 2024 and has held it in 6 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • R Squared held 54,985 shares of Lexicon Pharmaceuticals worth $132K as of Q2 2026.
  • R Squared sold 12,541 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $24.4K.
  • Lexicon Pharmaceuticals made up 0.07% of R Squared's portfolio in Q2 2026, its #381 holding.
  • R Squared first reported a position in Lexicon Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.